β4GalT-II increases cisplatin-induced apoptosis in HeLa cells depending on its Golgi localization

Biochemical and Biophysical Research Communications

Volumn 358, Issue 1, 2007, Pages 41-46

  Jiang, Jianhai ^a   Zhou, Jin ^a   Wei, Yuanyan ^a   Shen, Jialin ^a   Liu, Dan ^a   Chen, Xiaoning ^a   Zhang, Si ^a   Kong, Xiangfeig ^a   Yun, Xiaojing ^a   Gu, Jianxin ^a  

^a BEIJING HOSPITAL   (China)

Author keywords

4GalT II; Apoptosis; Cisplatin; Golgi localization; HeLa cells

Indexed keywords

BETA 1,4 GALACTOSYLTRANSFERASE II; CISPLATIN; GALACTOSYLTRANSFERASE; MESSENGER RNA; PROTEIN BAX; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; BETA-1,4-GALACTOSYLTRANSFERASE II; COL11A2 PROTEIN, HUMAN; COLLAGEN TYPE 11;

APOPTOSIS; ARTICLE; CELL SURVIVAL; GOLGI COMPLEX; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; TUMOR CELL; BIOSYNTHESIS; DRUG EFFECT; ENZYMOLOGY; GENETICS; HELA CELL; METABOLISM; MUTATION; PHYSIOLOGY;

ANTINEOPLASTIC AGENTS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CISPLATIN; COLLAGEN TYPE XI; GALACTOSYLTRANSFERASES; GOLGI APPARATUS; HELA CELLS; HUMANS; MUTATION; RNA, MESSENGER;

EID: 34248382466     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2007.04.044     Document Type: Article

References (31)

1. Nagata S. Apoptosis by death factor. Cell 88 (1997) 355-365
2. Hannun Y.A. Apoptosis and the dilemma of cancer chemotherapy. Blood 89 (1997) 1845-1853
3. Eastman A. Activation of programmed cell death by anticancer agents: cisplatin as a model system. Cancer Cells 2 (1990) 275-280
4. Alberts D.S., Garcia D., and Mason-Liddil N. Cisplatin in advanced cancer of the cervix: an update. Seminars in Oncology 18 (1991) 11-24
5. Chu G. Cellular responses to cisplatin. The roles of DNA-binding proteins and DNA repair. The Journal of Biological Chemistry 269 (1994) 787-790
6. Lo N.W., Shaper J.H., Pevsner J., and Shaper N.L. The expanding beta 4-galactosyltransferase gene family: messages from the databanks. Glycobiology 8 (1998) 517-526
7. Guo S., Sato T., Shirane K., and Furukawa K. Galactosylation of N-linked oligosaccharides by human beta-1,4-galactosyltransferases I, II, III, IV, V, and VI expressed in Sf-9 cells. Glycobiology 11 (2001) 813-820
8. Sasaki N., Manya H., Okubo R., Kobayashi K., Ishida H., Toda T., Endo T., and Nishihara S. beta4GalT-II is a key regulator of glycosylation of the proteins involved in neuronal development. Biochemical and Biophysical Research Communications 333 (2005) 131-137
9. Zhou D., Chen C., Jiang S., Shen Z., Chi Z., and Gu J. Expression of beta1,4-galactosyltransferase in the development of mouse brain. Biochimica et Biophysica Acta 1425 (1998) 204-208
10. Shirane K., Sato T., Segawa K., and Furukawa K. Involvement of beta-1,4-galactosyltransferase V in malignant transformation-associated changes in glycosylation. Biochemical and Biophysical Research Communications 265 (1999) 434-438
11. Xu S., Zhu X., Zhang S., Yin S., Zhou L., Chen C., and Gu J. Over-expression of beta-1,4-galactosyltransferase I, II, and V in human astrocytoma. Journal of Cancer Research and Clinical Oncology 127 (2001) 502-506
12. Zhu X., Jiang J., Shen H., Wang H., Zong H., Li Z., Yang Y., Niu Z., Liu W., Chen X., Hu Y., and Gu J. Elevated beta1,4-galactosyltransferase I in highly metastatic human lung cancer cells. Identification of E1AF as important transcription activator. The Journal of Biological Chemistry 280 (2005) 12503-12516
13. Jiang J., Shen J., Wu T., Wei Y., Chen X., Zong H., Zhang S., Sun M., Xie J., Kong X., Yang Y., Shen A., Wang H., and Gu J. Down-regulation of beta1,4-galactosyltransferase V is a critical part of etoposide-induced apoptotic process and could be mediated by decreasing Sp1 levels in human glioma cells. Glycobiology 16 (2006) 1045-1051
14. Jiang J., Chen X., Shen J., Wei Y., Wu T., Yang Y., Wang H., Zong H., Yang J., Zhang S., Xie J., Kong X., Liu W., and Gu J. Beta1,4-galactosyltransferase V functions as a positive growth regulator in glioma. The Journal of Biological Chemistry 281 (2006) 9482-9489
15. Sellers W.R., and Fisher D.E. Apoptosis and cancer drug targeting. The Journal of Clinical Investigation 104 (1999) 1655-1661
16. Yu S.W., Wang H., Poitras M.F., Coombs C., Bowers W.J., Federoff H.J., Poirier G.G., Dawson T.M., and Dawson V.L. Mediation of poly(ADP-ribose) polymerase-1-dependent cell death by apoptosis-inducing factor. Science 297 (2002) 259-263
17. Tentori L., Balduzzi A., Portarena I., Levati L., Vernole P., Gold B., Bonmassar E., and Graziani G. Poly (ADP-ribose) polymerase inhibitor increases apoptosis and reduces necrosis induced by a DNA minor groove binding methyl sulfonate ester. Cell Death and Differentiation 8 (2001) 817-828
18. Burlacu A. Regulation of apoptosis by Bcl-2 family proteins. Journal of Cellular and Molecular Medicine 7 (2003) 249-257
19. Sato T., Shirane K., Kido M., and Furukawa K. Correlated gene expression between beta-1,4-galactosyltransferase V and N-acetylglucosaminyltransferase V in human cancer cell lines. Biochemical and Biophysical Research Communications 276 (2000) 1019-1023
20. Zhang S., Cai M., Zhang S.W., Hu Y., and Gu J.X. Involvement of beta 1,4 galactosyltransferase 1 and Gal beta1->4GlcNAc groups in human hepatocarcinoma cell apoptosis. Molecular and Cellular Biochemistry 243 (2003) 81-86
21. Zhu X., Chen S., Yin X., Shen A., Ji S., Shen Z., and Gu J. Constitutively active PKB/Akt inhibited apoptosis and down-regulated beta1,4-galactosyltransferase 1 in hepatocarcinoma cells. Biochemical and Biophysical Research Communications 309 (2003) 279-285
22. de la Cruz L., Steffgen K., Martin A., McGee C., and Hathaway H. Apoptosis and involution in the mammary gland are altered in mice lacking a novel receptor, beta1,4-Galactosyltransferase I. Developmental Biology 272 (2004) 286-309
23. Li Z., Wang H., Zong H., Sun Q., Kong X., Jiang J., and Gu J. Downregulation of beta1,4-galactosyltransferase 1 inhibits CDK11(p58)-mediated apoptosis induced by cycloheximide. Biochemical and Biophysical Research Communications 327 (2005) 628-636
24. Crompton M. Bax, Bid and the permeabilization of the mitochondrial outer membrane in apoptosis. Current Opinion in Cell Biology 12 (2000) 414-419
25. Takagi-Morishita Y., Yamada N., Sugihara A., Iwasaki T., Tsujimura T., and Terada N. Mouse uterine epithelial apoptosis is associated with expression of mitochondrial voltage-dependent anion channels, release of cytochrome C from mitochondria, and the ratio of Bax to Bcl-2 or Bcl-X. Biology of Reproduction 68 (2003) 1178-1184
26. Leri A., Claudio P.P., Li Q., Wang X., Reiss K., Wang S., Malhotra A., Kajstura J., and Anversa P. Stretch-mediated release of angiotensin II induces myocyte apoptosis by activating p53 that enhances the local renin-angiotensin system and decreases the Bcl-2-to-Bax protein ratio in the cell. The Journal of Clinical Investigation 101 (1998) 1326-1342
27. Nguewa P.A., Fuertes M.A., Cepeda V., Alonso C., Quevedo C., Soto M., and Perez J.M. Poly(ADP-ribose) polymerase-1 inhibitor 3-aminobenzamide enhances apoptosis induction by platinum complexes in cisplatin-resistant tumor cells. Medicinal Chemistry (Shariqah, United Arab Emirates) 2 (2006) 47-53
28. Jamieson J.D. The Golgi complex: perspectives and prospectives. Biochimica et Biophysica Acta 1404 (1998) 3-7
29. Nozawa K., Casiano C.A., Hamel J.C., Molinaro C., Fritzler M.J., and Chan E.K. Fragmentation of Golgi complex and Golgi autoantigens during apoptosis and necrosis. Arthritis Research 4 (2002) R3
30. Machamer C.E. Golgi disassembly in apoptosis: cause or effect?. Trends in Cell Biology 13 (2003) 279-281
31. Kajimoto T., Shirai Y., Sakai N., Yamamoto T., Matsuzaki H., Kikkawa U., and Saito N. Ceramide-induced apoptosis by translocation, phosphorylation, and activation of protein kinase Cdelta in the Golgi complex. The Journal of Biological Chemistry 279 (2004) 12668-12676